STRC Research

Home

❯

sources

❯

lit

❯

FDA Approval of the Congenital OTOF Gene Therapy Otarmeni Reshapes the Future of Hearing Care.

FDA Approval of the Congenital OTOF Gene Therapy Otarmeni Reshapes the Future of Hearing Care.

May 19, 20261 min read

  • strc
  • hearing-loss
  • gene-therapy

What they found

(no abstract available)

How this applies to our program

Needs manual review. Relevance type auto-inferred as fda_path (score 4/10).

Key numbers

  • TBD — auto-scan caught this paper. Numbers extraction deferred to MinerU full-text parse if PDF retrieved.

Links

  • pubmed_id: https://pubmed.ncbi.nlm.nih.gov/42156605/
  • DOI: https://doi.org/10.1007/s10162-026-01053-z

Connections

  • [source] auto-indexed 2026-05-21 by strc-lit-watch

Graph View

  • What they found
  • How this applies to our program
  • Key numbers
  • Links
  • Connections

Backlinks

  • 2026-05-21-digest

Created with Quartz v4.5.2 © 2026

  • STRC marketing
  • Egor Lyfar
  • Contact